MYC and metabolic dysfunction-associated steatotic liver disease: It has associated targets with MAPK pathway, including the predicted key targets such as GSK3, MYC and IKBKG, which can be abnormally activated by various toxic insults or cellular stimuli related to NAFLD [26–28].